Open AccessImmunomodulating Nanomedicine for Cancer Therapy
Author(s) -
Zhigang Liu,
Wen Jiang,
Jutaek Nam,
James J. Moon,
Betty Y.S. Kim
Publication year - 2018
Publication title -
nano letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.853
H-Index - 488
eISSN - 1530-6992
pISSN - 1530-6984
DOI - 10.1021/acs.nanolett.8b02340
Subject(s) - nanomedicine , cancer therapy , drug delivery , nanotechnology , cancer , medicine , anticancer drug , drug , cancer treatment , targeted drug delivery , pharmacology , materials science , nanoparticle
Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom